Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03669302 · ClinicalTrials.gov registry record · NA
Activity-Dependent Transspinal Stimulation in SCI
A NA study, sponsored by City University of New York.
- Terminated
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT03669302: Clinical Trial NA study, sponsored by City University of New York.
NCT03669302 is a NA study that was terminated before completion, run by City University of New York. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03669302, a NA study, was terminated before completion, sponsored by City University of New York.
- TERMINATED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
Robotic gait training is often used with the aim to improve walking ability in individuals with Spinal Cord Injury. However, robotic gait training alone may not be sufficient. This study will compare the effects of robotic gait training alone to robotic gait training combined with either low-frequency or high-frequency non-invasive transspinal electrical stimulation. In people with motor-incomplete SCI, a series of clinical and electrical tests of nerve function will be performed before and after 20 sessions of gait training with or without stimulation.
Primary Outcome
Neurophysiological tests probing cortical and corticospinal excitability will be measured before and after the intervention. Single-pulse transcranial magnetic stimulation (TMS) will be used to assemble the recruitment curve of motor evoked potentials, and paired-pulse TMS will be used to probe changes in cortical inhibitory and facilitatory neuronal circuits.
Interventions
- OTHER Robotic gait training
- DEVICE Robotic gait training and low-frequency transspinal stimulation
- DEVICE Robotic gait training and high-frequency transspinal stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2018-08-01 |
| Est. Completion | 2021-10-02 |
| Phase | NA |
Why NCT03669302 stopped before completion
NCT03669302 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 3 interventions - of which Robotic gait training is the first listed.
NCT03669302 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03669302 about?
NCT03669302 is a clinical study titled "Activity-Dependent Transspinal Stimulation in SCI". Robotic gait training is often used with the aim to improve walking ability in individuals with Spinal Cord Injury. However, robotic gait training alone may not be sufficient. This study will compare the effects of robotic gait training alone to robotic gait training combined with either low-frequen...
What is the current status of trial NCT03669302?
This trial is currently terminated. It is a NA study. The enrollment target is 10 participants. The study started on 2018-08-01. Estimated completion is 2021-10-02.
What interventions are being tested in trial NCT03669302?
The interventions under investigation include: Robotic gait training (OTHER), Robotic gait training and low-frequency transspinal stimulation (DEVICE), Robotic gait training and high-frequency transspinal stimulation (DEVICE).
Who is sponsoring clinical trial NCT03669302?
This trial is sponsored by City University of New York, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03669302's enrollment target sits among peer trials
10 1927th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI